Oncology

Axillary lymphadenopathy following mRNA vaccination:

https://pubmed.ncbi.nlm.nih.gov/34156552/

Ipsilateral axillary adenopathy following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34333959/

4 cases of axillary adenopathy following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34303188/

Axillary adenopathy following AstraZeneca resulting in possible misinterpretation of PET scan in metastatic melanoma patient: https://pubmed.ncbi.nlm.nih.gov/34414110/

163 cases of axillary adenopathy following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34257025/

Incidence of axillary adenopathy on Breast Imaging following Vaccination: https://pubmed.ncbi.nlm.nih.gov/34292295/

Supraclavicular lymphadenopathy following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34414929/

Cervical lymphadenopathy following Pfizer:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204135/

13 cases of Cervical lymphadenopathy: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241354/

50yoM with adenopathy following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34406229/

Review of 24 cases of lymphadenopathy and their ultrasound findings in the US: https://pubmed.ncbi.nlm.nih.gov/34356507/

Kikucki-Fujimoto disease following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34395192/

Mammographic and sonographic findings in the breast and axillary tail following vaccination: https://pubmed.ncbi.nlm.nih.gov/34340203/

Vaccine related unilateral axillary lymphadenopathy:pattern on screening breast MRI: https://pubmed.ncbi.nlm.nih.gov/34325221/

Evolution of lymphadenopathy at PET/MRI after vaccination: https://pubmed.ncbi.nlm.nih.gov/34310229/

Axillary lymphadenopathy after COVID vaccination in patients with thoracic malignancy: https://pubmed.ncbi.nlm.nih.gov/34506955/

DOTATATE PET-avid axillary lymph node after injection of the Johnson & Johnson: https://pubmed.ncbi.nlm.nih.gov/34269723/

DOTATOC-avid lymphadenopathies induced by mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34363083/

3 cases of supraclavicular and axillary lymphadenopathy induced by vaccination on 18F-Fluorthanatrace, 68Ga-DOTATATE, and 18F-Fluciclovine PET/CT: https://pubmed.ncbi.nlm.nih.gov/34507331/

FDG uptake in axillary lymph nodes after vaccination: a pitfall case of highly suspicious lymph nodes metastases of malignant melanoma: https://pubmed.ncbi.nlm.nih.gov/34412144/

Avid left axillary nodes and intense diffuse splenic uptake and moderate diffuse bone marrow uptake on PET 1 week after vaccination: https://pubmed.ncbi.nlm.nih.gov/34269722/

Vaccination effect on tracer uptake with FDG-PET/CT: https://pubmed.ncbi.nlm.nih.gov/34297113/

Abnormal PET following vaccination: https://onlinelibrary.wiley.com/doi/full/10.1002/pbc.29262

Positive PET following vaccination: https://pubmed.ncbi.nlm.nih.gov/34301777/

False Positive FDG PET CT after vaccination in a woman treated for metastatic breast cancer: https://pubmed.ncbi.nlm.nih.gov/34308402/

The day after mass COVID vaccination: higher hypermetabolic lymphadenopathy detection on PET/CT and impact on oncologic management: https://pubmed.ncbi.nlm.nih.gov/34503150/

Temporal metabolic response to mRNA vaccinations in oncology patients: https://pubmed.ncbi.nlm.nih.gov/34463888/

Thymic hyperplasia after mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34462647/

Fatal systemic capillary leak syndrome after Johnson and Johnson vaccination in a multiple myeloma patient: https://pubmed.ncbi.nlm.nih.gov/34459725/

Moderna vaccination mimicking lymph-node progression in a patient with melanoma: https://pubmed.ncbi.nlm.nih.gov/34433198/

Post vaccination lymphadenopathy: report of cytological findings from fine needle aspiration biopsy: https://pubmed.ncbi.nlm.nih.gov/34432391/

Rituximab-induced acute lympholysis and pancytopenia after Moderna in a 71yoM with b-cell lymphoplasmacytic lymphoma: https://pubmed.ncbi.nlm.nih.gov/34429981/